Sichenzia Ross Ference Kesner LLP Represents Biotricity Inc. in $2.5 Million Registered Direct Offering
Press Release – New York, NY – December 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Biotricity Inc. (OTCQB:BTCY”) in a Registered Direct public offering of 450,164 registered shares of its common stock at a price of $5.50 per share for aggregate proceeds of approximately $2.5 million.
The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019